The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections

https://doi.org/10.1016/j.ijid.2022.03.059Get rights and content
Under a Creative Commons license
open access

Highlights

  • A case fatality rate decline may not imply that vaccines are effective in reducing deaths.

  • A constant case fatality rate can still mean that vaccines are effective in reducing deaths.

  • Detecting infections among both the vaccinated and unvaccinated population is key.

  • Unless vaccinated people are tested for COVID-19 infection, the case fatality rate loses meaning in tracking the pandemic.

Abstract

Objectives

This study aimed to test the behavior of the case fatality rate (CFR) in a mixed population of vaccinated and unvaccinated individuals by illustrating the role of both the effectiveness of vaccines in preventing deaths and the detection of infections among both the vaccinated (breakthrough infections) and unvaccinated individuals.

Methods

We simulated three hypothetical CFR scenarios that resulted from a different combination of vaccine effectiveness in preventing deaths and the efforts in detecting infections among both the vaccinated and unvaccinated individuals.

Results

In the presence of vaccines, the CFR depends not only on the effectiveness of vaccines in preventing deaths but also on the detection of breakthrough infections. As a result, a decline in the CFR may not imply that vaccines are effective in reducing deaths. Likewise, a constant CFR can still mean that vaccines are effective in reducing deaths.

Conclusions

Unless vaccinated people are also tested for COVID-19 infection, the CFR loses its meaning in tracking the pandemic. This shows that unless efforts are directed at detecting breakthrough infections, it is hard to disentangle the effect of vaccines in reducing deaths from the probability of detecting infections on the CFR.

Keywords

COVID-19
Vaccine effectiveness
Case Fatality Rate
Breakthrough Infections

Cited by (0)